LOGIN
Enoxaparin does not significantly reduce rates of deep vein thrombosis after TKA
August 2013
Enoxaparin does not significantly reduce rates of deep vein thrombosis after TKA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
VenaFlow plus Lovenox vs VenaFlow plus Aspirin for Thromboembolic Disease Prophylaxis in Total Knee Arthroplasty
J Arthroplasty. 2006 Sep;21(6 Suppl 2):139-43.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
275 patients undergoing unilateral total knee arthroplasty were randomized to receive spinal epidural anaesthesia, VenaFlow compression device, and enoxaparin or spinal epidural anaesthesia, VenaFlow compression device, and aspirin to prevent deep vein thrombosis. Enoxaparin and aspirin were taken for 4 weeks after surgery. Deep vein thrombosis was diagnosed through ultrasonography completed 3 to ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.